1. Home
  2. SES vs LCTX Comparison

SES vs LCTX Comparison

Compare SES & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SES
  • LCTX
  • Stock Information
  • Founded
  • SES 2012
  • LCTX 1990
  • Country
  • SES United States
  • LCTX United States
  • Employees
  • SES N/A
  • LCTX N/A
  • Industry
  • SES Auto Parts:O.E.M.
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SES Consumer Discretionary
  • LCTX Health Care
  • Exchange
  • SES Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • SES 110.3M
  • LCTX 127.7M
  • IPO Year
  • SES N/A
  • LCTX N/A
  • Fundamental
  • Price
  • SES $0.88
  • LCTX $0.59
  • Analyst Decision
  • SES Sell
  • LCTX Strong Buy
  • Analyst Count
  • SES 2
  • LCTX 5
  • Target Price
  • SES $1.25
  • LCTX $4.80
  • AVG Volume (30 Days)
  • SES 42.4M
  • LCTX 2.4M
  • Earning Date
  • SES 02-24-2025
  • LCTX 03-06-2025
  • Dividend Yield
  • SES N/A
  • LCTX N/A
  • EPS Growth
  • SES N/A
  • LCTX N/A
  • EPS
  • SES N/A
  • LCTX N/A
  • Revenue
  • SES N/A
  • LCTX $8,719,000.00
  • Revenue This Year
  • SES N/A
  • LCTX N/A
  • Revenue Next Year
  • SES N/A
  • LCTX $41.15
  • P/E Ratio
  • SES N/A
  • LCTX N/A
  • Revenue Growth
  • SES N/A
  • LCTX N/A
  • 52 Week Low
  • SES $0.20
  • LCTX $0.48
  • 52 Week High
  • SES $2.53
  • LCTX $1.61
  • Technical
  • Relative Strength Index (RSI)
  • SES 45.29
  • LCTX 52.01
  • Support Level
  • SES $0.76
  • LCTX $0.55
  • Resistance Level
  • SES $1.13
  • LCTX $0.60
  • Average True Range (ATR)
  • SES 0.32
  • LCTX 0.04
  • MACD
  • SES -0.13
  • LCTX 0.01
  • Stochastic Oscillator
  • SES 7.36
  • LCTX 83.38

About SES SES AI Corporation

SES AI Corp is a pre-commercialization stage company engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), urban air mobility (UAM), which encompasses electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: